 Monoclonal antibodies have been successfully used in cancer treatment for many years. They are able to target specific cancer cells while leaving healthy cells unharmed. This makes them a powerful tool in the fight against cancer. Antibody drug conjugates antibody oligonucleotides by specific multi-specific antibodies immunocytokines antibody fragments and scaffold proteins are all being developed to further improve the effectiveness of antibodies in cancer treatment. These new technologies are allowing researchers to develop more effective treatments with fewer side effects. This article was authored by Shijie Jin, Yang Ping Sun, Xiao Liang, and others.